{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:07:44Z","timestamp":1790204864669,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"unrestricted research grant provided by Shoppers Drug Mart"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Pharmacists are taking on more roles in helping to close the gap in care for sexually transmitted infection (STI) management services. The acceptability of pharmacists to perform these services is not yet well understood. The objective of this review was to map, characterize, and explicate the acceptability of pharmacist-delivered STI services.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A scoping review was conducted. Three databases (PubMed, Embase, and CINAHL) were searched up to July 2024 for articles relating to the acceptability of pharmacists to independently assess and manage issues relating to STIs. The results were then mapped to the theoretical framework of acceptability (TFA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>A total of 2181 publications were identified. 22 studies met inclusion criteria and assessed at least one outcome aligning within the constructs of the TFA. Services relating to pre-exposure prophylaxis prescribing, point-of-care testing, chlamydia (and gonorrhea) testing and treatment, and human papillomavirus vaccine prescribing were identified. The overall acceptability of pharmacist-delivered STI services was high across the constructs of the TFA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This review outlines that the acceptability of pharmacists to provide STI management is high and pharmacists are willing to take on accountability for these services. Pharmacists believe that they have a moral obligation to improve the health and wellbeing of their patients, while, decreasing the burden on the broader health care system.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ijpp\/riaf039","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T14:12:45Z","timestamp":1749737565000},"page":"369-377","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacists\u2019 acceptability of provision of sexually transmitted infection services: a scoping review"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9633-5903","authenticated-orcid":false,"given":"Kathleen M","family":"Bergin","sequence":"first","affiliation":[{"name":"College of Pharmacy, Faculty of Health, Dalhousie University , PO Box 15000, Halifax, Nova Scotia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily K","family":"Black","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Faculty of Health, Dalhousie University , PO Box 15000, Halifax, Nova Scotia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L","family":"Murphy","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Faculty of Health, Dalhousie University , PO Box 15000, Halifax, Nova Scotia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah V","family":"Kelly","sequence":"additional","affiliation":[{"name":"Memorial University of Newfoundland School of Pharmacy , St. John\u2019s, Newfoundland and Labrador ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1670-2512","authenticated-orcid":false,"given":"Kyle John","family":"Wilby","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Faculty of Health, Dalhousie University , PO Box 15000, Halifax, Nova Scotia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"2025072423420832100_CIT0001","author":"World Health Organization"},{"key":"2025072423420832100_CIT0002","author":"Centers for Disease Control","year":"2022"},{"key":"2025072423420832100_CIT0003","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2025072423420832100_CIT0004","author":"World Health Organization"},{"key":"2025072423420832100_CIT0005","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.japh.2023.10.029","article-title":"Pharmacy-based sexually transmitted infection service implementation considerations: a scoping review","volume":"64","author":"d\u2019Entremont-Harris","year":"2024","journal-title":"J Am Pharmacists Assoc : JAPhA"},{"key":"2025072423420832100_CIT0006","author":"Centers for Disease Control and Prevention (CDC)","year":"2021"},{"key":"2025072423420832100_CIT0007","author":"Government of Canada","year":"2023"},{"key":"2025072423420832100_CIT0008","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12913-023-09028-z","article-title":"Disruptions of sexually transmitted and blood borne infections testing services during the COVID-19 pandemic: accounts of service providers in Ontario, Canada","volume":"23","author":"Ryu","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"2025072423420832100_CIT0009","doi-asserted-by":"publisher","first-page":"e047034","DOI":"10.1136\/bmjopen-2020-047034","article-title":"Sexual and reproductive health services provided by community pharmacists: a scoping review","volume":"11","author":"Navarrete","year":"2021","journal-title":"BMJ Open"},{"key":"2025072423420832100_CIT0010","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1186\/s12889-020-08719-0","article-title":"Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study","volume":"20","author":"Kelly","year":"2020","journal-title":"BMC Public Health"},{"key":"2025072423420832100_CIT0011","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/sextrans-2019-054096","article-title":"Pharmacy-based sexual health services: a systematic review of experiences and attitudes of pharmacy users and pharmacy staff","volume":"95","author":"Gauly","year":"2019","journal-title":"Sex Transm Infect"},{"key":"2025072423420832100_CIT0012","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"2025072423420832100_CIT0013","doi-asserted-by":"publisher","first-page":"2633489520936644","DOI":"10.1177\/2633489520936644","article-title":"Measuring implementation outcomes: an updated systematic review of measures\u2019 psychometric properties","volume":"1","author":"Mettert","year":"2020","journal-title":"Implement Res Pract"},{"key":"2025072423420832100_CIT0014","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/bjhp.12677","article-title":"Application of the theoretical framework of acceptability in a surgical setting: theoretical and methodological insights","volume":"28","author":"Paynter","year":"2023","journal-title":"Br J Health Psychol"},{"key":"2025072423420832100_CIT0015","author":"Covidence Systematic Review","year":"2022"},{"key":"2025072423420832100_CIT0016","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.srhc.2018.03.006","article-title":"Readiness of pharmacists and consumers for pharmacy-based chlamydia screening in Australia and Switzerland","volume":"16","author":"Arnet","year":"2018","journal-title":"Sex Reprod Healthc"},{"key":"2025072423420832100_CIT0017","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/qshc.2006.020883","article-title":"Chlamydia testing in community pharmacies: Evaluation of a feasibility pilot in south east London","volume":"16","author":"Baraitser","year":"2007","journal-title":"Qual Saf Health Care"},{"key":"2025072423420832100_CIT0018","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.japh.2021.08.001","article-title":"An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay Area pharmacies","volume":"62","author":"Bellman","year":"2022","journal-title":"J Am Pharmacists Assoc : JAPhA"},{"key":"2025072423420832100_CIT0019","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/17151635231152218","article-title":"Community pharmacists\u2019 acceptance of prescribing pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)","volume":"156","author":"Booker","year":"2023","journal-title":"Canadian Pharmacists Journal : CPJ = Revue des pharmaciens du Canada : RPC"},{"key":"2025072423420832100_CIT0020","doi-asserted-by":"publisher","first-page":"e0207372","DOI":"10.1371\/journal.pone.0207372","article-title":"Midwest pharmacists\u2019 familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV. Smith DK, editor","volume":"13","author":"Broekhuis","year":"2018","journal-title":"PLoS One"},{"key":"2025072423420832100_CIT0021","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jac5.1773","article-title":"A survey of South Carolina pharmacists\u2019 readiness to prescribe human immunodeficiency virus pre-exposure prophylaxis","volume":"6","author":"Burns","year":"2023","journal-title":"J Am Coll Clin Pharm"},{"key":"2025072423420832100_CIT0022","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/j.1471-0528.2007.01506.x","article-title":"Willingness of gynaecologists, doctors in family planning, GPs, practice nurses and pharmacists to adopt novel interventions for treating sexual partners of women with chlamydia","volume":"114","author":"Cameron","year":"2007","journal-title":"BJOG"},{"key":"2025072423420832100_CIT0023","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.japh.2019.12.003","article-title":"Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men","volume":"60","author":"Crawford","year":"2020","journal-title":"J Am Pharm Assoc: JAPhA"},{"key":"2025072423420832100_CIT0024","doi-asserted-by":"publisher","first-page":"100088","DOI":"10.1016\/j.rcsop.2021.100088","article-title":"Community pharmacist engagement in HIV and HCV prevention: Current practices and potential for service uptake","volume":"4","author":"Dowling-McClay","year":"2021","journal-title":"Explor Res Clin Soc Pharm"},{"key":"2025072423420832100_CIT0025","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s11096-022-01444-1","article-title":"Point-of-care HIV and hepatitis screening in community pharmacies: a quantitative and qualitative study","volume":"44","author":"Figueira","year":"2022","journal-title":"Int J Clin Pharm"},{"key":"2025072423420832100_CIT0026","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/pharmacy8040206","article-title":"Staff and users\u2019 experiences of pharmacy-based sexual and reproductive health services: a qualitative interview study from the UK","volume":"8","author":"Gauly","year":"2020","journal-title":"Pharmacy"},{"key":"2025072423420832100_CIT0027","doi-asserted-by":"publisher","first-page":"ofz365","DOI":"10.1093\/ofid\/ofz365","article-title":"Acceptability and feasibility of a pharmacist-led human immunodeficiency virus pre-exposure prophylaxis program in the Midwestern United States","volume":"6","author":"Havens","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025072423420832100_CIT0028","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.japh.2020.10.005","article-title":"Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: examining concordance between pharmacy technicians and pharmacists","volume":"61","author":"Hopkins","year":"2021","journal-title":"J Am Pharm Assoc: JAPhA"},{"key":"2025072423420832100_CIT0029","doi-asserted-by":"publisher","first-page":"ofad549","DOI":"10.1093\/ofid\/ofad549","article-title":"Opportunities to increase access to HIV prevention: Evaluating the implementation of pharmacist-initiated pre-exposure prophylaxis in California","volume":"10","author":"Hunter","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025072423420832100_CIT0030","doi-asserted-by":"publisher","first-page":"100255","DOI":"10.1016\/j.rcsop.2023.100255","article-title":"Facilitating human papillomavirus vaccination pathways by extending vaccination competencies to community pharmacists: A cross-sectional survey on the acceptability and expectations among healthcare professionals and parents","volume":"10","author":"Julia","year":"2023","journal-title":"Explor Res Clin Soc Pharm"},{"key":"2025072423420832100_CIT0031","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/j.japh.2020.06.005","article-title":"Attitudes about community pharmacy access to HIV prevention medications in California","volume":"60","author":"Koester","year":"2020","journal-title":"J Am Pharmacists Association : JAPhA"},{"key":"2025072423420832100_CIT0032","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/pharmacy9020084","article-title":"Addressing barriers to HIV point-of-care testing in community pharmacies","volume":"9","author":"McKeirnan","year":"2021","journal-title":"Pharmacy"},{"key":"2025072423420832100_CIT0033","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1331\/JAPhA.2013.12240","article-title":"Pharmacists\u2019 perspectives on HIV testing in community pharmacies","volume":"53","author":"Ryder","year":"2013","journal-title":"J Am Pharm Assoc: JAPhA"},{"key":"2025072423420832100_CIT0034","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1071\/SH16031","article-title":"Australian pharmacists\u2019 willingness to conduct rapid HIV testing in community pharmacies","volume":"13","author":"Santella","year":"2016","journal-title":"Sex Health"},{"key":"2025072423420832100_CIT0035","doi-asserted-by":"publisher","first-page":"10","DOI":"10.24926\/iip.v10i1.1425","article-title":"Pharmacists\u2019 opinions on the implementation of HIV and HepC point-of-care testing in a U.S. pharmacy chain","volume":"10","author":"So","year":"2019","journal-title":"Innov Pharm"},{"key":"2025072423420832100_CIT0036","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/j.2055-2335.2007.tb00767.x","article-title":"Acceptance of a Chlamydia screening program in community pharmacies","volume":"37","author":"Taylor","year":"2007","journal-title":"Pharm Pract Res"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/33\/4\/369\/63480018\/riaf039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/33\/4\/369\/63480018\/riaf039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T03:42:17Z","timestamp":1753414937000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/33\/4\/369\/8161154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,6,12]]},"published-print":{"date-parts":[[2025,7,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ijpp\/riaf039","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,6,12]]}}}